Dosage ; Benign gastric ulcer; 20mg OD x 6/52.
Benign duodenal ulcer; 20mg OD x 4/52.
Reflux oesophagitis; 20mg OD x 4/52 or more.
NB: The tablet should be swallowed whole with
a full glass of water since it is enteric-coated to prevent
gastric decomposition and to increase bioavailability.
Rabeprazole Brands;
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Barole | Global Pharma Healthcare Pvt. Ltd | Medox Pharmaceuticals Ltd. | 20mg | 14 | Capsule | per capsule | KES 1,150.00 |
| Prompto | Getz Pharmaceuticals | Surgipharm Ltd | 20mg | 10 | Tablet | per tablet | KES 268.00 |
| Rabemac | Macleods Pharmaceuticals Ltd. | Sai Pharmaceuticals Ltd. | 20mg | 30 | Tablet | per tablet | KES 328 |
| Rabosec | Innocia Life Sciences PVT. Ltd | Pharma Specialities Ltd. | 20mg | 30 | Tablet | per tablet | KES 482.00 |
| Veloze- | Torrent Pharmaceuticals Ltd. | Medox Pharmaceuticals Ltd. | 20mg | 30 | Capsule | per capsule | KES 800 |
| Rabeloc | Cadila Pharmaceuticals Ltd. | Cadila Pharmaceuticals (EA) | 20mg | 10 | Tablet | per tablet | KES 425.00 |
| Rabeloc | Cadila Pharmaceuticals Ltd. | Cadila Pharmaceuticals (EA) | 20mg | 1 | Injection | per vial | KES 780.00 |
| Rabekind | Mankind Pharma Limited | Pharma Specialities Ltd. | 20mg | 60 | Tablet | per tablet | KES 956.00 |
| Rabemac | Macleods Pharmaceuticals Ltd. | Sai Pharmaceuticals Ltd. | 20mg | 60 | Tablet | per tablet | KES 462.00 |
| Rabeto | Flamingo Heat Pad | Harley's Limited | 20mg | 10 | Tablet | per tablet | KES 105.00 |
| Rabtas | Intas Pharmaceuticals Ltd | Medisel Kenya Ltd | 10mg | 20 | Tablet | per tablet | KES 400.00 |
| Rabtas | Intas Pharmaceuticals Ltd | Medisel Kenya Ltd | 20mg | 30 | Tablet | per tablet | KES 1,100.00 |
| Razid | Global Pharma Healthcare Pvt. Ltd | Medox Pharmaceuticals Ltd. | 20mg | 20 | Tablet | per tablet | KES 510.00 |
| Strirab | Gufic Stridden | Sunpar Pharmaceuticals Ltd. | 20mg | 50 | Tablet | per tablet | KES 1,280.00 |
| Strirab | Gufic Stridden | Sunpar Pharmaceuticals Ltd. | 20mg | 10ml | Injection | per vial | KES 540.00 |
| Rabeprazole More info; | |
|---|---|
| Mode Of Action | Proton pump inhibition |
| Drug Indication | Duodenal ulcers, benign gastric ulcers, and prevention of peptic ulcers associated with NSAIDs, reflux oesophagitis, Zollinger-Ellison syndrome |
| Precautions | Exclude possibility of malignancy, hepatic damage, pregnancy and breastfeeding |
| Side Effects | Apnea, convulsions, hematological abnormalities (specifically agranulocytosis, hemolytic anemia, leukopenia or neutropenia, pancytopenia or thrombocytopenia, hematuria), hepatitis, headache, asthenia or malaise, constipation; dizziness; dyspepsia, flatulence, nausea and vomiting, paresthesia, pruritus, somnolence, stomach pain. |
| Dosage | Benign gastric ulcer; 20mg OD x 6/52. Benign duodenal ulcer; 20mg OD x 4/52. Reflux oesophagitis; 20mg OD x 4/52 or more. NB: The tablet should be swallowed whole with a full glass of water since it is enteric-coated to prevent gastric decomposition and to increase bioavailability. FDA Pregnancy risk category: B |
| Special Information | Rabeprazole is a substituted benzimidazole |
| Drug Category | DRUGS ACTING ON ALIMENTARY SYSTEM |
| Drug Sub-Category | Proton pump inhibitors (PPIs) |